dsdsa

product

Wholesale 99% Sofosbuvir - Pharmaceutical Grade 209216-23-9 Entecavir Monohydrate For Treatment of Chronic Hepatitis B – Yibai

Short Description:


Product Detail

FAQ

Product Tags

Related Video

Feedback (2)

Our eternal pursuits are the attitude of "regard the market, regard the custom, regard the science" and the theory of "quality the basic, trust the first and management the advanced" for Lorcaserin, Bpc 157, Rocuronium Bromide Powder, We believe we will become a leader in developing and producing high quality products in both Chinese and international markets. We hope to cooperate with more friends for mutual benefits.
Wholesale 99% Sofosbuvir - Pharmaceutical Grade 209216-23-9 Entecavir Monohydrate For Treatment of Chronic Hepatitis B – Yibai Detail:

Product name Entecavir monohydrate
Synonyms 2-Amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one monohydrate
CAS No. 209216-23-9
Appearance White to off-white powder
Molecular Formula C12H15N5O3.H2O
Molecular Weight 295.30
Usage Pharmaceutical Grade or Research purpose
Packing As per your request
Storage Preserve in tight,light-resistant containers in a cool place

 

Entecavir monohydrate Cas: 209216-23-9

Items

Standard

Results

Appearance White to off-white powder Complies
Optical rotation +24.0°—+28.0°(DMF:MeOH=1:1 c=1%) +27.0°
Identification A: By IR, To match with working standard Complies
B: By HPLC,retain time should match with working standard Complies
Water 5.8%—6.5% 6.1%
Isomer Single ≤0.1% 0.02%
Total ≤0.5% 0.02%
Related Substances Single impurity ≤0.1% 0.05%
Total impurities ≤0.3% 0.07%
Residue on ignition ≤0.1% 0.04%
Heavy metals £ 10ppm Complies
Residual  solvents Should be to match with the standard Complies
Assay ≥99.8% 99.9%
Conclusion:Complies to the in-house standards.

Company Information

√ Management layer’s full experience in factory and skilled technicians followers;
√ Quality is always our top consideration, Strict QC system;
√ 11 years experienced exporting sales team;
√ Independent R&D lab;
√ Two signed long term GMP workshops;
√ Rich resources of plenty idle factories for customized project;
√ High Efficiency working team with consistent path.
imgsafSDGSHDASFG

Product detail pictures:

Wholesale 99% Sofosbuvir - Pharmaceutical Grade 209216-23-9  Entecavir Monohydrate For Treatment of Chronic Hepatitis B – Yibai detail pictures

Wholesale 99% Sofosbuvir - Pharmaceutical Grade 209216-23-9  Entecavir Monohydrate For Treatment of Chronic Hepatitis B – Yibai detail pictures

Wholesale 99% Sofosbuvir - Pharmaceutical Grade 209216-23-9  Entecavir Monohydrate For Treatment of Chronic Hepatitis B – Yibai detail pictures


Related Product Guide:

We enjoy a very good reputation among our customers for our excellent product quality, competitive price and the best service for Wholesale 99% Sofosbuvir - Pharmaceutical Grade 209216-23-9 Entecavir Monohydrate For Treatment of Chronic Hepatitis B – Yibai , The product will supply to all over the world, such as: Poland, Mexico, Oman, We take measure at any expense to achieve essentially the most up-to-date equipment and approaches. The packing of nominated brand is our a further distinguishing feature. The items to assure years of trouble-free service has attracted a great deal customers. The solutions are obtainable in improved designs and richer assortment, they're created scientifically of purely raw supplies. It readily available in a variety of designs and specifications for your selection. The most recent kinds are a great deal better than the preceding one particular and they are quite popular with lots of prospects.
  • Product variety is complete, good quality and inexpensive, the delivery is fast and transport is security, very good, we are happy to cooperate with a reputable company!
    5 Stars By Katherine from Islamabad - 2017.11.11 11:41
    In China, we have purchased many times, this time is the most successful and most satisfactory, a sincere and realiable Chinese manufacturer!
    5 Stars By Modesty from Saudi Arabia - 2017.03.28 16:34
    Write your message here and send it to us